ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,749Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 4623

$2.12M Total Retail Price of All Prescriptions

Rank: 15 out of 4623

1,343 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,343 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 1,343 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,216 680 S3 1 3
PRAVASTATIN SODIUM 1,203 898 2 11
METFORMIN HCL 781 557 3 6
LEVOTHYROXINE SODIUM 719 572 4 1
AMLODIPINE BESYLATE 687 582 5 5
OMEPRAZOLE 670 488 6 7
CRESTOR 622 445 7 20
TRAMADOL HCL 568 420 8 15
LISINOPRIL 566 429 9 4
CITALOPRAM HBR 532 323 10 23
NEXIUM 499 304 11 17
LOSARTAN-HYDROCHLOROTHIAZIDE 480 409 12 46
ALENDRONATE SODIUM 480 398 12 22
FUROSEMIDE 437 364 14 8
METOPROLOL SUCCINATE 424 351 15 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 400 309 16 19
METOPROLOL TARTRATE 400 293 16 9
ZOLPIDEM TARTRATE 392 227 18 18
AMLODIPINE BESYLATE-BENAZEPRIL 379 286 19 55
FENOFIBRATE 368 266 20 54
SIMVASTATIN 323 278 21 2
HYDROCHLOROTHIAZIDE 316 224 22 10
PANTOPRAZOLE SODIUM 283 176 23 35
CIPROFLOXACIN HCL 253 191 24 43
ATORVASTATIN CALCIUM 250 175 25 12
GABAPENTIN 234 139 26 16
POTASSIUM CHLORIDE 223 176 27 14
CARVEDILOL 217 192 28 25
CLOPIDOGREL 211 153 29 31
DILTIAZEM ER 210 180 30 179
DONEPEZIL HCL 196 196 31 30
ADVAIR DISKUS 195 129 32 62
ETODOLAC 195 141 32 160
GLIMEPIRIDE 191 157 34 38
LOSARTAN POTASSIUM 190 155 35 21
ISOSORBIDE MONONITRATE ER 181 137 36 60
ENALAPRIL MALEATE 179 122 37 41
TAMSULOSIN HCL 177 155 38 29
DIOVAN HCT 171 147 39 67
CYMBALTA 164 71 40 48
TRAZODONE HCL 155 55 41 42
PLAVIX 154 122 42 45
JANUVIA 152 119 43 52
DIOVAN 144 105 44 39
NYSTATIN-TRIAMCINOLONE 144 112 44 199
INSULIN SYRINGE 141 99 46 85
FLUTICASONE PROPIONATE 140 112 47 32
RANITIDINE HCL 137 89 48 47
CLONIDINE HCL 135 87 49 40
BENAZEPRIL HCL 135 105 49 70
LEVOFLOXACIN 134 103 51 81
ESCITALOPRAM OXALATE 134 77 51 75
SINGULAIR 134 68 51 83
POLYETHYLENE GLYCOL 3350 133 106 54 91
VENTOLIN HFA 126 71 55 134
IBUPROFEN 125 59 56 65
CYCLOBENZAPRINE HCL 124 38 R 57 53
DICLOFENAC SODIUM 121 78 58 121
GLIPIZIDE 120 92 59 49
MIRTAZAPINE 119 100 60 57
PREDNISONE 116 76 61 50
TRIAMTERENE-HCTZ 112 88 62 80
LANTUS SOLOSTAR 111 78 63 105
ACTOS 111 91 63 87
ONGLYZA 110 92 65 192
MELOXICAM 106 77 66 27
NIFEDIPINE ER 104 87 67 97
NOVOLOG MIX 70-30 103 82 68 200
ALLOPURINOL 102 97 69 37
RISPERIDONE 94 71 70 72
SERTRALINE HCL 91 60 71 26
COMBIVENT 91 75 71 162
MONTELUKAST SODIUM 90 49 73 158
EXFORGE 89 69 74 181
CELEBREX 88 58 75 89
DEXILANT 88 73 75 232
PROAIR HFA 87 49 77 64
MECLIZINE HCL 86 57 78 125
ATENOLOL 81 58 79 28
DILTIAZEM 24HR CD 80 55 80 156
FAMOTIDINE 79 66 81 82
PAROXETINE HCL 76 67 82 78
SPIRONOLACTONE 76 51 82 77
EVISTA 75 75 84 128
LOVASTATIN 75 65 84 34
PHENYTOIN SODIUM EXTENDED 74 38 86 119
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 55 87 68
CILOSTAZOL 72 67 88 176
AZITHROMYCIN 70 51 89 33
GLYBURIDE 69 60 R 90 59
ACTOPLUS MET 69 46 90 354
LANTUS 68 48 92 44
OXYBUTYNIN CHLORIDE 68 49 92 120
TERBINAFINE HCL 66 37 94 323
MEGESTROL ACETATE 66 64 R 94 145
TRICOR 65 49 96 88
DETROL LA 64 52 97 196
JANUMET 63 48 98 136
METOLAZONE 62 57 99 208
ACTONEL 62 62 99 165
CLINDAMYCIN HCL 59 40 101 236
VOLTAREN 59 45 101 182
ESTRADIOL 59 39 R 101 130
KLOR-CON M20 58 46 104 102
WARFARIN SODIUM 58 47 104 24
HUMALOG MIX 75-25 57 42 106 307
NITROGLYCERIN PATCH 57 53 106 190
PEN NEEDLE 56 36 108 122
HYDROXYZINE HCL 56 29 R 108 138
ABILIFY 56 15 108 161
MUPIROCIN 56 40 108 159
NASONEX 56 16 108 171
FLUOXETINE HCL 55 30 113 61
CARISOPRODOL 54 0 R 114 71
LYRICA 53 24 115 66
HUMALOG 53 44 115 186
DOXAZOSIN MESYLATE 52 52 117 98
KLOR-CON 10 52 40 117 187
CEFDINIR 51 27 119 129
PIOGLITAZONE HCL 50 39 R 120 230
NAPROXEN 50 36 120 63
NOVOLOG MIX 70-30 FLEXPEN 50 26 120 223
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.